Rafarm S.A

About Rafarm S.A

Rafarm is a Greek pharmaceutical company with extended experience in the development, manufacturing, out-licensing and marketing of pharmaceutical products. We grow together; Planning with care for the future by continuously investing in our GMP facility and strong team of qualified professionals, in order to deliver to you, a wide range of products and services fully customized to suit your needs. Specialized in ophthalmic and sterile products, we also offer solids, semisolids, liquids and creams always implementing our philosophy “Health care. Human care.”. Today we celebrate over 47 years of experience and the  recent FDA approval of our sterile line.

  • GR
  • 2015
    On CPhI since
Contact info

Products from Rafarm S.A

  • MOXIFLOXACIN HYDROCHLORIDE eye drops solution

    Product MOXIFLOXACIN HYDROCHLORIDE eye drops solution

    Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Conjunctivitis Innovator: Moxivig (Novartis)
  • CLOPIDOGREL BESILATE f.c. tablets

    Product CLOPIDOGREL BESILATE f.c. tablets

    Strength: 75 mg/tab Therapeutic area: Anti-thrombotic Innovator: Plavix (Sanofi-Aventis)
  • AMIKACIN solution for injection

    Product AMIKACIN solution for injection

    Strength: 500 mg/2 ml Presentation: vials, 2 ml Therapeutic area: Anti-infective Innovator: Briklin 
  • ATORVASTATIN f.c. tablets

    Product ATORVASTATIN f.c. tablets

    Strength: 10 mg/tab; 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Diseases Innovator: Lipitor (Pfizer)
  • BIMATOPROST + TIMOLOL eye drops solution

    Product BIMATOPROST + TIMOLOL eye drops solution

    Strength: (0.3 mg+5 mg)/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Ganfort (Allergan)
  • BIMATOPROST eye drops solution

    Product BIMATOPROST eye drops solution

    Strength: 0.3 mg/ml; 0.1 mg/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Lumigan (Allergan)
  • BRIMONIDINE + TIMOLOL eye drops solution

    Product BRIMONIDINE + TIMOLOL eye drops solution

    Strength: (2 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Combigan (Allergan)
  • BRIMONIDINE eye drops solution

    Product BRIMONIDINE eye drops solution

    Strength: 2 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Alphagan (Allergan)
  • DEXAMETHASONE PRESERVATIVE FREE eye drops solution

    Product DEXAMETHASONE PRESERVATIVE FREE eye drops solution

    Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Treatment of inflammatory conditions of the anterior segment of the eye Innovator: Dexafree (Laboratoires THEA)
  • DEXAMETHASONE soluble tablets

    Product DEXAMETHASONE soluble tablets

    Strength:  0.5 mg/tab; 2 mg/tab; 4 mg/tab; 8 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Glucocorticoid Therapy Innovator: - (-)
  • DONEPEZIL f.c. tablets

    Product DONEPEZIL f.c. tablets

    Strength: 5 mg/tab; 10 mg/tab Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
  • DONEPEZIL oral solution

    Product DONEPEZIL oral solution

    Strength: 1 mg/ml Presentation: bottles, 150 ml Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)